Trial reportJournal of neurology2025
Cognitive stimulation in Parkinson's disease with mild cognitive impairment.
Trial report in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Impact of Virtual Reality-Based Therapies on Cognition and Depression in Patients With Parkinson Disease: Systematic Review and Meta-Analysis of Randomized Controlled Trials.JMIR serious games · 2026Review
- Mindfulness combined with cognitive motor dual task training in Parkinson's disease with mild cognitive impairment.iScience · 2026Article
- Effectiveness of virtual reality-based nature interventions in promoting mental health outcomes among older adults with cognitive impairment: a systematic review and meta-regression analysis.Australian journal of psychology · 2026Review
- Integrated bio-cooperative robotic platform for virtual cognitive training in Parkinson's disease: design and methodology of the OPERA project.Frontiers in neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundCognitive impairment is among the most frequent and disabling non-motor symptoms of Parkinson's disease (PD), often emerging early and substantially impacting autonomy and quality of life. While cognitive stimulation (CS) is supported in other neurodegenerative conditions, its role in PD is less explored. This study aimed to compare the efficacy of a therapist-guided, home-based CS program, delivered via a virtual reality rehabilitation system, with a conventional in-person CS intervention.
methodsOf 123 individuals screened, 45 patients with PD and mild cognitive impairment (PD-MCI) were randomized to either the tele-rehabilitation group (TRG; n = 25) or the control group (CG; n = 20). Both groups received the same standardized 4-week CS program (20 multi-domain sessions, 5 days/week), targeting memory, attention, executive functions, language, and visuospatial skills. The TRG trained at home via the VRRS platform under remote supervision, while the CG attended outpatient sessions. Neuropsychological and clinical outcomes were assessed at baseline (T1), post-intervention (T2), and 6-month follow-up (T3). Analyses included repeated-measures ANOVA, multivariate linear regression, and categorical comparisons based on predefined clinical cut-offs.
resultsAll participants completed the intervention with adherence exceeding 90% in both groups. At T2, the TRG showed greater improvements than the CG in global cognition, working memory, and delayed recall. These effects remained significant after adjusting for age, sex, baseline performance, and cognitive reserve index, and were robust to false discovery rate correction. Regression models confirmed these improvements. Categorical analyses also showed a marked reduction in pathological scores in the TRG in the same domains.
conclusionA short-term, therapist-guided CS program delivered via tele-rehabilitation effectively improved cognitive functioning in PD-MCI, with partial benefits maintained at 6 months, especially in memory and executive domains. The intervention was particularly beneficial for memory and executive functions, highlighting telemedicine as a promising and accessible option for cognitive care in PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.